Intuitive Surgical (NASDAQ:ISRG) Insider Sells $13,019,717.34 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Gary Guthart sold 22,806 shares of Intuitive Surgical stock in a transaction on Monday, December 1st. The shares were sold at an average price of $570.89, for a total value of $13,019,717.34. Following the completion of the transaction, the insider owned 2,694 shares in the company, valued at $1,537,977.66. The trade was a 89.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $568.63 on Friday. The business has a 50-day moving average of $515.92 and a two-hundred day moving average of $505.59. The firm has a market capitalization of $203.84 billion, a PE ratio of 75.22, a P/E/G ratio of 5.24 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently bought and sold shares of ISRG. Tobam grew its position in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth $27,000. TD Capital Management LLC increased its position in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ISRG. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Argus raised their price objective on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $607.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.